Greater Cannabis Company (GCAN) Debt to Equity (2016 - 2022)

Greater Cannabis Company's Debt to Equity history runs 7 years deep, the most recent figure standing at -$0.48 for Q4 2022.

• In Q4 2022, Debt to Equity rose 13.91% year-over-year to -$0.48; the TTM figure through Dec 2022 stood at -$0.48 (up 13.91% YoY), while the FY2022 annual figure was -$0.48, up 13.91% from the prior year.
• Debt to Equity was -$0.48 for Q4 2022 at Greater Cannabis Company, down from -$0.46 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $3.3 in Q1 2018 to a low of -$3.01 in Q2 2021.
• Historically, Debt to Equity has averaged -$0.25 across 5 years, with a median of -$0.46 in 2020.
• The sharpest annual moves came in 2018 and 2022: Debt to Equity plunged 1861.36% in 2018, then soared 86.53% in 2022.
• A 5-year view of Debt to Equity shows it stood at -$0.5 in 2018, then soared by 66.19% to -$0.17 in 2019, then jumped by 62.92% to -$0.06 in 2020, then sank by 789.2% to -$0.55 in 2021, then rose by 13.91% to -$0.48 in 2022.
• The last three Debt to Equity figures came in at -$0.48 (Q4 2022), -$0.46 (Q3 2022), and -$0.41 (Q2 2022), per Business Quant data.